Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
*Terms apply
7.2 episodes per 100 patient-years of exposure, respectively)
Retatrutide Half-life: ~68 days Dosing: Once weekly subcutaneous injection Profile: Triple receptor activity supports more dramatic weight loss outcomes, with sustained pharmacologic coverage across the dosing interval Why the Comparison Matters While Retatrutides half-life is similar to semaglutide and tirzepatide, its efficacy appears greater because of its triple agonism
, ,
The interactions of oxyntomodulin differed, with more transient contacts deep within the peptide binding cavity and with residues located higher within TM2, and with ECL2
[ Google scholar ] Al-Abdullah IH, Ayala G, Panigrahi D, Kumar A M, Kumar MSA
